Articles producció científica> Bioquímica i Biotecnologia

How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?

  • Dades identificatives

    Identificador: imarina:9326311
    Handle: https://hdl.handle.net/20.500.11797/imarina9326311
    Autors:
    Paz-Graniel, IBabio, NNishi, SKMartinez-Gonzalez, MACorella, DFito, MMartinez, AAlonso-Gomez, AMWarnberg, JVioque, JRomaguera, DLopez-Miranda, JEstruch, RTinahones, FJSantos-Lozano, JMSerra-Majem, JLBueno-Cavanillas, ATur, JASanchez, VMPinto, XDelgado-Rodriguez, MMatia-Martin, PVidal, JCalderon-Sanchez, CDaimiel, LRos, EFernandez-Aranda, FToledo, EValle-Hita, CSorli, JVLassale, CGarcia-Rios, AOncina-Canovas, ABaron-Lopez, FJZulet, MARayo, ECasas, RThomas-Carazo, ETojal-Sierra, LDamas-Fuentes, MRuiz-Canela, Mde las Heras-delgado, SFernandez-Carrion, RCastaner, OPena-Orihuela, PJGonzalez-Palacios, SBuil-Cosiales, PGoday, ASalas-Salvado, J
    Resum:
    Background and Aims. To control the COVID-19 spread, in March 2020, a forced home lockdown was established in Spain. In the present study, we aimed to assess the effect of mobility and social COVID-19-established restrictions on depressive symptomatology in older adults with metabolic syndrome. We hypothesize that severe restrictions might have resulted in detrimental changes in depressive symptomatology. Methods. 2,312 PREDIMED-Plus study participants ( men = 53.9 %; mean age = 64.9 ± 4.8 years) who completed a COVID-19 lockdown questionnaire to assess the severity of restrictions/lockdown and the validated Spanish version of the Beck Depression Inventory-II (BDI-II) during the three established phases concerning the COVID-19 lockdown in Spain (prelockdown, lockdown, and postlockdown) were included in this longitudinal analysis. Participants were categorized according to high or low lockdown severity. Analyses of covariance were performed to assess changes in depressive symptomatology across lockdown phases. Results. No significant differences in participant depression symptomatology changes were observed between lockdown severity categories (low/high) at the studied phases. During the lockdown phase, participants showed a decrease in BDI-II score compared to the prelockdown phase (mean (95% CI), -0.48 (-0.24, -0.72), P < 0.001 ); a nonsignificantly larger decrease was observed in participants allocated in the low-lockdown category (low: -0.59 (-0.95, -0.23), high: -0.43 (-0.67, -0.19)). Similar decreases in depression symptomatology were found for the physical environment dimension. The post- and prelockdown phase BDI-II scores were roughly similar. Conclusions. The COVID-19 pandemic lockdown was associated with a decrease in depressive symptomatology that returned to

  • Altres:

    Autor segons l'article: Paz-Graniel, I; Babio, N; Nishi, SK; Martinez-Gonzalez, MA; Corella, D; Fito, M; Martinez, A; Alonso-Gomez, AM; Warnberg, J; Vioque, J; Romaguera, D; Lopez-Miranda, J; Estruch, R; Tinahones, FJ; Santos-Lozano, JM; Serra-Majem, JL; Bueno-Cavanillas, A; Tur, JA; Sanchez, VM; Pinto, X; Delgado-Rodriguez, M; Matia-Martin, P; Vidal, J; Calderon-Sanchez, C; Daimiel, L; Ros, E; Fernandez-Aranda, F; Toledo, E; Valle-Hita, C; Sorli, JV; Lassale, C; Garcia-Rios, A; Oncina-Canovas, A; Baron-Lopez, FJ; Zulet, MA; Rayo, E; Casas, R; Thomas-Carazo, E; Tojal-Sierra, L; Damas-Fuentes, M; Ruiz-Canela, M; de las Heras-delgado, S; Fernandez-Carrion, R; Castaner, O; Pena-Orihuela, PJ; Gonzalez-Palacios, S; Buil-Cosiales, P; Goday, A; Salas-Salvado, J
    Departament: Bioquímica i Biotecnologia
    Autor/s de la URV: Babio Sánchez, Nancy Elvira / De las Heras Delgado, Sara / Nishi, Stephanie Kimiko / Paz Graniel, Indira del Socorro / Salas Salvadó, Jorge / Valle Hita, Cristina
    Paraules clau: Good health and well-being
    Resum: Background and Aims. To control the COVID-19 spread, in March 2020, a forced home lockdown was established in Spain. In the present study, we aimed to assess the effect of mobility and social COVID-19-established restrictions on depressive symptomatology in older adults with metabolic syndrome. We hypothesize that severe restrictions might have resulted in detrimental changes in depressive symptomatology. Methods. 2,312 PREDIMED-Plus study participants ( men = 53.9 %; mean age = 64.9 ± 4.8 years) who completed a COVID-19 lockdown questionnaire to assess the severity of restrictions/lockdown and the validated Spanish version of the Beck Depression Inventory-II (BDI-II) during the three established phases concerning the COVID-19 lockdown in Spain (prelockdown, lockdown, and postlockdown) were included in this longitudinal analysis. Participants were categorized according to high or low lockdown severity. Analyses of covariance were performed to assess changes in depressive symptomatology across lockdown phases. Results. No significant differences in participant depression symptomatology changes were observed between lockdown severity categories (low/high) at the studied phases. During the lockdown phase, participants showed a decrease in BDI-II score compared to the prelockdown phase (mean (95% CI), -0.48 (-0.24, -0.72), P < 0.001 ); a nonsignificantly larger decrease was observed in participants allocated in the low-lockdown category (low: -0.59 (-0.95, -0.23), high: -0.43 (-0.67, -0.19)). Similar decreases in depression symptomatology were found for the physical environment dimension. The post- and prelockdown phase BDI-II scores were roughly similar. Conclusions. The COVID-19 pandemic lockdown was associated with a decrease in depressive symptomatology that returned to prelockdown levels after the lockdown. The degree of lockdown was not associated with depressive symptomatology. The potential preventive role of the physical environment and social interactions on mental disorders during forced home lockdown should be further studied. This trial is registered with ISRCTN89898870. Retrospectively registered on 24 July 2014.
    Àrees temàtiques: Saúde coletiva Psychology, clinical Psychology Psychiatry and mental health Psychiatry Psicología Medicina ii Medicina i Interdisciplinar General medicine Engenharias iv Educação física Clinical psychology Ciencias sociales Ciências biológicas ii
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: stephanie.nishi@urv.cat indiradelsocorro.paz@urv.cat sara.delasheras@urv.cat sara.delasheras@urv.cat cristina.valle@estudiants.urv.cat indiradelsocorro.paz@urv.cat jordi.salas@urv.cat nancy.babio@urv.cat
    Identificador de l'autor: 0000-0002-3204-6877 0000-0002-3204-6877 0000-0003-2700-7459 0000-0003-3527-5277
    Data d'alta del registre: 2024-11-23
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Depression And Anxiety. 2023 1-9
    Referència de l'ítem segons les normes APA: Paz-Graniel, I; Babio, N; Nishi, SK; Martinez-Gonzalez, MA; Corella, D; Fito, M; Martinez, A; Alonso-Gomez, AM; Warnberg, J; Vioque, J; Romaguera, D; (2023). How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?. Depression And Anxiety, 2023(), 1-9. DOI: 10.1155/2023/6765950
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2023
    Tipus de publicació: Journal Publications

  • Paraules clau:

    Clinical Psychology,Psychiatry,Psychiatry and Mental Health,Psychology,Psychology, Clinical
    Good health and well-being
    Saúde coletiva
    Psychology, clinical
    Psychology
    Psychiatry and mental health
    Psychiatry
    Psicología
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Engenharias iv
    Educação física
    Clinical psychology
    Ciencias sociales
    Ciências biológicas ii

  • Documents:

    DocumentPrincipal

  • Cerca a google

    Search to google scholar